⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1320422 | 1.00 | — | — | |
| SCHEMBL11211818 | 1.00 | — | — | |
| SCHEMBL6416315 | 1.00 | — | — | |
| SCHEMBL11206000 | 1.00 | — | — | |
| SCHEMBL11205919 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL3455926 | 0.88 | — | — | |
| SCHEMBL29894251 | 0.78 | — | — | |
| SCHEMBL41921 | 0.78 | — | — | |
| SCHEMBL6702143 | 0.73 | ALDH1A1 (0.50) | — | |
| SCHEMBL6651106 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| US-20230204604-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2023-06-29 | — | — | US | claimed |
| CN-114787363-A | Genetic engineering of fungi to modulate tryptamine expression | 恩派瑞安神经科学公司 | 2022-07-22 | — | — | CN | claimed |
| US-20190310269-A1 | SYSTEMS AND METHODS FOR MEASURING OBESITY USING METABOLOME ANALYSIS | HUMAN LONGEVITY, INC. | 2019-10-10 | — | — | US | claimed |
| US-8541567-B2 | Transition state structure of 5′-methylthioadenosine/s-adenosylhomocysteine nucleosidases | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2013-09-24 | — | — | US | claimed |
| EP-2036984-B1 | Reversion of the negative selective effect of negative marker proteins as selection procedure | BASF PLANT SCIENCE GMBH (DE) | 2012-02-22 | — | — | EP | claimed |
| EP-1527183-B1 | NOVEL SELECTION METHOD | BASF PLANT SCIENCE GMBH (DE) | 2008-08-20 | — | — | EP | claimed |
| US-20060218658-A1 | Novel selection method | BASF PLANT SCIENCE GMBH (DE) | 2006-09-28 | — | — | US | claimed |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | disclosed |
| US-20260076944-A1 | COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH | UNIV CALIFORNIA (US) | 2026-03-19 | — | — | US | disclosed |
| US-20250375505-A1 | COMPOSITIONS AND METHODS FOR MODIFYING BILE ACIDS TO REGULATE LIPID AND STEROID METABOLISM | UNIV CALIFORNIA (US) | 2025-12-11 | — | — | US | disclosed |
| US-12428629-B2 | Engineered uridine phosphorylase variant enzymes | CODEXIS, INC. (US) | 2025-09-30 | — | — | US | disclosed |
| US-12391937-B2 | Biosynthesis of products from 1-carbon compounds | MOJIA BIOTECH PTE. LTD. (SG) | 2025-08-19 | — | — | US | disclosed |
| EP-4580609-A2 | COMPOSITIONS AND METHODS FOR DELIVERY OF RNA | Rejuvenation Technologies Inc. (US) | 2025-07-09 | — | — | EP | disclosed |
| EP-0690919-A4 | CRUCIFER ACC SYNTHASE AND USES THEREOF | GEN HOSPITAL CORP (US) | 1995-11-16 | — | — | EP | disclosed |
| WO-1995014092-A1 | DNA, DNA CONSTRUCTS, CELLS AND PLANTS DERIVED THEREFROM | ZENECA LIMITED (GB) | 1995-05-26 | — | — | WO | disclosed |
| WO-1994024294-A1 | USE OF TOMATO E8-DERIVED PROMOTERS TO EXPRESS HETEROLOGOUS GENES, E.G. S-ADENOSYLMETHIONINE HYDROLASE, IN RIPENING FRUIT | EPITOPE, INC. (US) | 1994-10-27 | — | — | WO | disclosed |
| WO-1994008449-A1 | CRUCIFER ACC SYNTHASE AND USES THEREOF | THE GENERAL HOSPITAL CORPORATION (US) | 1994-04-28 | — | — | WO | disclosed |
| CN-1013448-B | N6Process for producing-substituted deoxyriboadenosine analogues | WARNER LAMBERT CO (US) | 1991-08-07 | — | — | CN | disclosed |
| CN-85108658-A | N 6The manufacture method that replaces ribodesose adenyhomotype thing | — | 1986-07-16 | — | — | CN | disclosed |